The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Relationship between genetic markers and quality of life (QOL) in stage III colon cancer (CC) patients (pts) prior to adjuvant treatment (N0147).
Jeff A. Sloan
No relevant relationships to disclose
Qian Shi
No relevant relationships to disclose
Adam Lee
No relevant relationships to disclose
Robert B. Diasio
No relevant relationships to disclose
Emily S Pavey
No relevant relationships to disclose
Daniel J. Sargent
No relevant relationships to disclose
Richard M. Goldberg
No relevant relationships to disclose
Frank A. Sinicrope
No relevant relationships to disclose
Michelle R. Mahoney
No relevant relationships to disclose
Steven R. Alberts
No relevant relationships to disclose